Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Loranger Steven R, Director. Officer active across 2 companies, notably Edwards Lifesciences Corp. Cumulatively, 9 reports have been published. Activity tracked since 5 May 2021. The latest transaction was filed on 9 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Steven R. Loranger is a Director at Edwards Lifesciences Corp and Xylem Inc. In this role, he participates in the strategic direction of these companies and important decision-making. His expertise in the healthcare and water technology sectors is valuable to the board.